Enhanc3D Genomics

Silver Sponsor

Information

Enhanc3D Genomics has established a genome-wide 3D-sequencing platform (GenLink3D) using proprietary technology that can globally connect enhancer regions and GWAS (genome-wide association study) risk loci to their therapeutically targetable genes. Enhanc3D Genomics is applying this technology to multiple therapeutic areas, including immunology and immune-oncology. Enhanc3D Genomics is now actively seeking pharma partners and additional growth investors to further translate its unique “big-data” position in the field of functional genomics and precision medicine.

Exhibitor Profile
Biotechnology

Social media

Contact details

info@enhanc3dgenomics.com
https://enhanc3dgenomics.com/
The Jeffreys Building
Cowley Road, CB4 0AP, Milton, England, United Kingdom

Sessions

3D Genomics: The Next Dimension of Discovery

Thursday, October 10, 2024 2:50 PM to 3:10 PM
Precision Medicine Diagnostics and Therapies
Hazel Jones · Enhanc3D Genomics

Documents & Links

Enhanc3D Genomics - The Next Dimension of DiscoveryDynamic animation providing an overview of Enhanc3D Genomics and the technology.

Team

Hazel Jones
Hazel Jones
Interim Chief Executive Officer and Chief Operating OfficerEnhanc3D Genomics
Kishen Chahwala
Kishen Chahwala
Business Development ManagerEnhanc3D Genomics

Log in